Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer antidiabetic drugs are generally cost-effective, though access varies by income level and drug pricing.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer diabetes drugs show cost-effectiveness, but affordability varies by country income levels and treatment timing.
By Peptide Association Research Team
New research reveals how existing drugs like metformin and GLP-1 agonists may offer alternative approaches to Alzheimer's treatment through repurposing strategies.
By Peptide Association Research Team
Research reveals how mitochondria-targeted liposomes enhance thermogenesis in fat cells, offering potential obesity treatment through improved cellular metabolism.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's disease treatment, offering hope beyond current limited therapies.
By Peptide Association Research Team
New research reveals alarming connections between childhood obesity and cardiovascular disease. Study examines 381 million affected children worldwide.
By Peptide Association Research Team
Study reveals how spray-drying parameters affect injectable peptide suspension stability through advanced multimodal analysis techniques.
By Peptide Association Research Team
Recent research reveals 81% of newer antidiabetic drugs are cost-effective in developed countries, but accessibility remains limited in developing nations.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team
New research across 34 countries reveals how physical and social environmental factors accelerate brain aging by up to 9-fold in both healthy individuals and those with dementia.
By Peptide Association Research Team
New research explores repurposing existing drugs for Alzheimer's treatment, highlighting mitochondrial-targeted therapies and multi-target approaches.
By Peptide Association Research Team
New research suggests IL-15 plus thymosin alpha-1 may help reverse T cell aging in liver cancer models. Learn about this promising peptide combination study.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team
Recent study reveals tirzepatide achieved 22.7% weight loss at 52 weeks using telehealth protocol. Learn clinical implications for peptide therapy providers.
By Peptide Association Research Team
New nanoencapsulation research reveals enhanced neuroprotection against brain injury. Learn implications for thymosin beta 4 injury treatment approaches.
By Peptide Association Research Team
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 peptide reveals neuroprotective mechanisms in stroke models. Study findings on mitochondrial peptide therapy for brain health.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New research on retatrutide, a triple-agonist peptide therapy, demonstrates significant benefits for type 2 diabetes and obesity management in clinical studies.
By Peptide Association Research Team